Anshul Thakur1, Michael Goldbaum2, Siamak Yousefi3,4. 1. School of Computing and Electrical EngineeringIndian Institute of Technology MandiMandi175005India. 2. Department of OphthalmologyUniversity of California San DiegoSan DiegoCA92093USA. 3. Department of OphthalmologyThe University of Tennessee Health Science CenterMemphisTN38163USA. 4. Department of Genetics, Genomics, and InformaticsThe University of Tennessee Health Science CenterMemphisTN38163USA.
Abstract
Goal: The purpose of this study was to identify clinically relevant patterns of glaucomatous vision loss through convex representation to predict glaucoma several years prior to disease onset. Methods: We developed a deep archetypal analysis to identify patterns of glaucomatous vision loss, and then projected visual fields over the identified patterns. Projections provided a representation that was more accurate in detecting glaucomatous vision loss, thus, more appropriate for recognizing preclinical signs of glaucoma prior to disease development. To overcome the class imbalance in prediction, we implemented a class-balanced bagging with neural networks. Results: Using original visual field as features of the class-balanced bagging classification provided an area under the receiver-operating characteristic curve (AUC) of 0.55 for predicting glaucoma approximately four years prior to disease development. Using convex representation of the visual fields as input features provided an AUC of 0.61 while using deep convex representation as input features improved the AUC to 0.71. Relevance vector machine (RVM) achieved an AUC of 0.64. Conclusion: Deep archetypal analysis representation of visual functional features with balanced bagging classification could serve as an automated tool for predicting glaucoma. Significance: Glaucoma is the second leading cause of worldwide blindness. Most people with glaucoma have no early symptoms or pain, delaying diagnosis in many patients until they reach late irreversible vision loss stages. In fact, about 50% of people with glaucoma are unaware they have the disease. Deep archetypal analysis models may impact clinical practice in effectively identifying at-risk glaucoma patients well prior to disease development.
Goal: The purpose of this study was to identify clinically relevant patterns of glaucomatous vision loss through convex representation to predict glaucoma several years prior to disease onset. Methods: We developed a deep archetypal analysis to identify patterns of glaucomatous vision loss, and then projected visual fields over the identified patterns. Projections provided a representation that was more accurate in detecting glaucomatous vision loss, thus, more appropriate for recognizing preclinical signs of glaucoma prior to disease development. To overcome the class imbalance in prediction, we implemented a class-balanced bagging with neural networks. Results: Using original visual field as features of the class-balanced bagging classification provided an area under the receiver-operating characteristic curve (AUC) of 0.55 for predicting glaucoma approximately four years prior to disease development. Using convex representation of the visual fields as input features provided an AUC of 0.61 while using deep convex representation as input features improved the AUC to 0.71. Relevance vector machine (RVM) achieved an AUC of 0.64. Conclusion: Deep archetypal analysis representation of visual functional features with balanced bagging classification could serve as an automated tool for predicting glaucoma. Significance: Glaucoma is the second leading cause of worldwide blindness. Most people with glaucoma have no early symptoms or pain, delaying diagnosis in many patients until they reach late irreversible vision loss stages. In fact, about 50% of people with glaucoma are unaware they have the disease. Deep archetypal analysis models may impact clinical practice in effectively identifying at-risk glaucoma patients well prior to disease development.
Authors: Christopher Bowd; Intae Lee; Michael H Goldbaum; Madhusudhanan Balasubramanian; Felipe A Medeiros; Linda M Zangwill; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2012-04-30 Impact factor: 4.799
Authors: Mae O Gordon; Julia A Beiser; James D Brandt; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Michael A Kass Journal: Arch Ophthalmol Date: 2002-06
Authors: Tobias Elze; Louis R Pasquale; Lucy Q Shen; Teresa C Chen; Janey L Wiggs; Peter J Bex Journal: J R Soc Interface Date: 2015-02-06 Impact factor: 4.118
Authors: Henry D Jampel; David Friedman; Harry Quigley; Susan Vitale; Rhonda Miller; Frederick Knezevich; Yulan Ding Journal: Am J Ophthalmol Date: 2008-09-13 Impact factor: 5.258
Authors: Christopher Bowd; Robert N Weinreb; Madhusudhanan Balasubramanian; Intae Lee; Giljin Jang; Siamak Yousefi; Linda M Zangwill; Felipe A Medeiros; Christopher A Girkin; Jeffrey M Liebmann; Michael H Goldbaum Journal: PLoS One Date: 2014-01-30 Impact factor: 3.240
Authors: Siamak Yousefi; Madhusudhanan Balasubramanian; Michael H Goldbaum; Felipe A Medeiros; Linda M Zangwill; Robert N Weinreb; Jeffrey M Liebmann; Christopher A Girkin; Christopher Bowd Journal: Transl Vis Sci Technol Date: 2016-05-03 Impact factor: 3.283
Authors: Mengyu Wang; Lucy Q Shen; Louis R Pasquale; Paul Petrakos; Sydney Formica; Michael V Boland; Sarah R Wellik; Carlos Gustavo De Moraes; Jonathan S Myers; Osamah Saeedi; Hui Wang; Neda Baniasadi; Dian Li; Jorryt Tichelaar; Peter J Bex; Tobias Elze Journal: Invest Ophthalmol Vis Sci Date: 2019-01-02 Impact factor: 4.799
Authors: Xiaoqin Huang; Fatemeh Saki; Mengyu Wang; Tobias Elze; Michael V Boland; Louis R Pasquale; Chris A Johnson; Siamak Yousefi Journal: J Glaucoma Date: 2022-06-03 Impact factor: 2.290